A randomized phase III trial comparing two dose-dense, dose-intensified approaches (ETC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer.
Contact
Project management
Konstantin Reißmüller
geparocto@gbg.de
+4961027480440
